Astellas Pharma Inc. Overview
Pro stress-test →Astellas Pharma Inc. manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally. The company is a specialty international pharmaceutical company focused on accelerating the discovery, development, and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases.
Strategic Profile
Pro stress-test →The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. Astellas is experiencing strong global sales trends of XTANDI for prostate cancer and BETANIS/MYRBETRIQ/BETMIGA for overactive bladder.
Competitive Landscape
Pro stress-test →One of Astellas Pharma's 64 competitors is Novartis, a Corporation company based in Basel, Switzerland. Loss of exclusivity for major drugs and persistent R&D challenges threaten future revenue stability, while pricing pressures, regulatory risks, and supply chain complexities increase margin volatility across key global markets.
Industry Context
Astellas Pharma Inc. operates in Pharmaceutical Manufacturing - General.
Key facts
Founded: 1923 · Headquarters: Chuo, Japan · Revenue: $13.4B · Market cap: $28.9B